About CU Healthcare Innovation Fund
CU Healthcare Innovation Fund is a venture capital firm founded in 2019. It is primarily based out of Aurora, United States. As of May 2025, CU Healthcare Innovation Fund is an active investor, having invested in 27 companies, with 3 new investments in the last 12 months. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from HealthTech to Life Sciences and Enterprise Applications. Most recently it led the $33M Series B round of Foresight Diagnostics along with Foresite Capital. This round also saw participation from Agent Capital and other investors.
Overall, CU Healthcare Innovation Fund portfolio has seen 1 IPO and 4 acquisitions including key companies like Q32 Bio, Amplifire and Cured. A lot of funds co-invest with CU Healthcare Innovation Fund, with names like UCHealth sharing a substantial percentage of its portfolio.
CU Healthcare Innovation Fund has team of 6 people including 3 partners.
Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Series B & 1 more
Portfolio IPOs
Portfolio Acquisitions
Portfolio Soonicorns
Deals in last 12 months
CU Healthcare Innovation Fund's List of Top Investments
CU Healthcare Innovation Fund has a portfolio of 27 companies. Their most notable investments are in Carta Healthcare and Foresight Diagnostics.Their portfolio spans across and United States. They have invested in HealthTech, Life Sciences, Enterprise Applications and 6 other sectors, across stages such as Series A, Series B and 1 more. Here is the list of top investments by CU Healthcare Innovation Fund:AI-based clinical data management tool for providers. The company has developed products like 'ATLAS', 'SEMAPHORE', 'NAVIGATOR', and more. The products have solutions and features for data interpretation, analytical application, patient data management, and more.
Key facts about Carta Healthcare
- Founded Year: 2017
- Location: San Mateo (United States)
- Stage: Series B
- Total Funding till date: $80.5M
- Employee Count: 57 as on Dec 31, 2021
- Investors: Maverick Ventures, Asset Management Ventures and 26 Others
- Latest Funding Round: Series B, May 08, 2025, $18.2M
- Highlight: Editors' Pick
Developer of a single-use patch for vital signs monitoring. It develops a DaaS platform, smart button, and smart sticker to monitor vital signs and manage health. Its device is attached to the upper left chest and the data is captured by the platform to enable remote patient monitoring by healthcare providers.
Key facts about BioIntelliSense
- Founded Year: 2018
- Location: Redwood City (United States)
- Stage: Series B
- Total Funding till date: $82M
- Employee Count: 26 as on Dec 31, 2022
- Investors: ID Ventures America, Chimera and 12 Others
- Latest Funding Round: Series B, Jul 28, 2021, $45M
- Highlight: Editors' Pick
3. 410 Medical
Provider of rapid infusion system for critically ill patients. The company's products include "LifeFlow Fluid Infuser", which allows healthcare providers to deliver fluids quickly and efficiently to critically ill patients.
Key facts about 410 Medical
- Founded Year: 2012
- Location: Durham (United States)
- Stage: Series B
- Total Funding till date: $66M
- Investors: Defense.gov, Sea Purity Investments and 18 Others
- Latest Funding Round: Series B, Mar 17, 2025, $14M
4. Babyscripts
Online platform offering toolkit for tech-enabled prenatal and postpartum care. The company offers a mommy kit that will include internet-connected medical devices that allow checking the blood pressure, weight, or glucose levels of the patient. The mobile app delivers custom content to patients related to nutrition, exercise, and other behaviors in a healthy pregnancy. The company offers mobile applications for Android and iOS platforms.
Key facts about Babyscripts
- Founded Year: 2013
- Location: Washington, DC (United States)
- Stage: Series B
- Total Funding till date: $37M
- Employee Count: 17 as on Dec 31, 2021
- Investors: Kensington Capital Partners, Ysios Capital and 32 Others
- Latest Funding Round: Series B, Nov 30, 2021, $7.5M
- Highlight: Editors' Pick
5. GoCheck Kids
GoCheck Kids developed by Gobiquity, is a mobile application for the early detection and tracking of eye diseases in children. Its applications enable parents to perform tests at home and in primary care situations using mobile computing platforms, such as iPhones and iPads. The app enables pediatricians to detect risks of amblyopia (the leading cause of vision loss in children) by simply snapping a picture of a child's eyes.
Key facts about GoCheck Kids
- Founded Year: 2011
- Location: Portland (United States)
- Stage: Series C
- Total Funding till date: $26M
- Employee Count: 35 as on Dec 31, 2022
- Investors: InterWest Partners, Hatteras Venture Partners and 14 Others
- Latest Funding Round: Series C, Oct 20, 2021, $10M
- Highlight: Editors' Pick
CU Healthcare Innovation Fund's Year-on-Year Investment Trends
CU Healthcare Innovation Fund has invested in 27 companies over the last 5 years, with an average of 3 new investments annually in the last 5 years. In 2024, it made 4 investments, while as of May 2025, it has made 2 investments in this year. Its most recent first time investment was in 410 Medical and most recent follow-on round was in Carta Healthcare.
Year | No. of Investments | ||
---|---|---|---|
1st Round | Follow-on | Total | |
2025 (YTD) | 1 | 1 | 2 |
2024 | 4 | 0 | 4 |
2023 | 0 | 1 | 1 |
2022 | 3 | 1 | 4 |
2021 | 6 | 0 | 6 |
2020 | 2 | 0 | 2 |
Get CU Healthcare Innovation Fund's portfolio delivered to your inbox!
CU Healthcare Innovation Fund's Investments by Stage
CU Healthcare Innovation Fund has made 8 investments in Series A stage with an average round size of $22M, 7 investments in Series B stage with an average round size of $30.9M and 1 investment in Series C stage with an average round size of $10M.Note: We have considered here, only first round of investments
Stage of entry | No. of Investments |
---|---|
Series A | 8 |
Series B | 7 |
Series C | 1 |
CU Healthcare Innovation Fund's Investments by Sector
CU Healthcare Innovation Fund has a diverse portfolio, with companies operating in the HealthTech, Enterprise Applications, Life Sciences, High Tech and Healthcare. Notably, it has invested in 24 Tech companies, 20 Enterprise (B2B) companies, 15 Software companies and at least 4 companies focusing on Consumer (B2C).
Note: We have considered here, only first round of investments
Sector | No. of Investments |
---|---|
HealthTech | 10 |
Enterprise Applications | 7 |
Life Sciences | 6 |
High Tech | 4 |
Healthcare | 2 |
Others | 7 |
CU Healthcare Innovation Fund's Investments by Geography
CU Healthcare Innovation Fund has made most investments in United States (16).
CU Healthcare Innovation Fund's recent investments
Here are the most recent investments by CU Healthcare Innovation Fund:
Date | Company | Location | Round Details | Round Amount | Co-Investors |
---|---|---|---|---|---|
May 08, 2025 | United States | Series B | $18.2M | UPMC [+8] | |
Mar 17, 2025 | United States | Series B | $14M | ||
Jul 30, 2024 | United States | Series B | $33M | Foresite Capital [+5] | |
Jul 24, 2024 | United States | Series B | $36M | Northwell [+2] | |
May 29, 2024 | United States | Series A | $10M | UCHealth [+2] |
IPOs and Publicly Listed companies in CU Healthcare Innovation Fund's Portfolio
Here are CU Healthcare Innovation Fund's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
---|---|---|---|---|
Dec 09, 2021 | Oct 29, 2020 | Series B | $60M |
Acquired companies in CU Healthcare Innovation Fund's Portfolio
Here are CU Healthcare Innovation Fund's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
---|---|---|---|---|
Jun 04, 2025 | Jan 10, 2024 | Series A | $22.5M | |
Sep 04, 2024 | Mar 24, 2020 | Series A | $3.6M | |
Jan 16, 2024 | Sep 15, 2021 | Series A | $10M | |
Jul 25, 2022 | - | - | - |
Team profile of CU Healthcare Innovation Fund
CU Healthcare Innovation Fund has a team of 6 members including 3 Partners and 1 Principal located in United States. CU Healthcare Innovation Fund's team does not sit on the board of any company as of now.Here is a list of all team members in CU Healthcare Innovation Fund:
Name | Designation | Location | Board Memberships | Contact details |
---|---|---|---|---|
Partner | Crested Butte | - | ||
Partner | New York City | - | ||
Partner | Aurora | - | ||
Principal | Denver | - | ||
Associate | Denver | - | - |
Co-investors of CU Healthcare Innovation Fund
Over the past 5 years, 134 investors have co-invested in CU Healthcare Innovation Fund's portfolio companies.
- Invested before CU Healthcare Innovation Fund: Sovereign's Capital, P5 Health Ventures and 52 others have invested in rounds before CU Healthcare Innovation Fund. There are 2 companies where Sovereign's Capital has invested before CU Healthcare Innovation Fund and 2 companies where P5 Health Ventures has invested before CU Healthcare Innovation Fund.
- Top Co-investors of CU Healthcare Innovation Fund: 59 investors entered a company along with CU Healthcare Innovation Fund. These include investors like UCHealth (3 companies).
- Invested after CU Healthcare Innovation Fund: A total of 21 investors have invested in CU Healthcare Innovation Fund's portfolio after their investments. Top Investors include Memorial Hermann (2 companies), Paramark Ventures (1 company) and Frist Cressey Ventures (1 company).
Get full list of CU Healthcare Innovation Fund's co-investors delivered to your inbox!
Recent News related to CU Healthcare Innovation Fund
•
Clarapath Closes $36M Series B FundingFinSMEs•Jul 24, 2024•Clarapath, Northwell, CU Healthcare Innovation Fund, Mayo Clinic and 1 other
•
Hummingbird Healthcare Secures $10M to Streamline Patient Access, Create JobsHIT Consultant•Jul 02, 2024•Hummingbird, UCHealth, CU Healthcare Innovation Fund, 8VC and 1 other
•
Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 MillionPR Newswire•Mar 26, 2024•Q32 Bio, Homology Medicines, Orbimed, Atlas Venture and 14 others
•
Suicide prevention telehealth provider Vita Health receives $22.5MMobiHealthNews•Jan 10, 2024•Vita Health, LFE Capital, CVS Health, Athyrium Capital Management and 4 others
•
Carta Healthcare Closes $25M Series B FundingFinSMEs•Jun 08, 2023•Carta Healthcare, Memorial Hermann, UnityPoint Health, Frist Cressey Ventures and 7 others
•
Carta Healthcare Raises $25M for AI-Powered Clinical Data AbstractionHIT Consultant•Jun 08, 2023•Carta Healthcare, Memorial Hermann, UnityPoint Health, Paramark Ventures and 7 others
•
ClinOne Closes Series A Funding Round to Scale its Site andPRWeb•Apr 14, 2023•ClinOne, Boulder Ventures, CU Healthcare Innovation Fund, First Trust Capital Partners
•
CodaMetrix Closes $55M Series A FundingFinSMEs•Feb 28, 2023•CODAMETRIX, SignalFire, Frist Cressey Ventures, Martin Ventures and 3 others
•
Sensorium scores $30M to change risk-value proposition in CNS drug discoveryMed Ad News•Nov 08, 2022•Sensorium Therapeutics, Sante, Route 66 Ventures, CU Healthcare Innovation Fund
•
Carta Healthcare Secures $20 Million Series B Funding to Help Additional Health Systems Improve Patient Care Amid Challenging Global Economy, Pandemic Turbulence, and Downturn in VC FundingBusiness Wire•Nov 02, 2022•Carta Healthcare, Paramark Ventures, Frist Cressey Ventures, American College of Cardiology and 6 others